Delayed onset muscle soreness (DOMS) management: present state of the art

This paper reviews existing theories explaining the delayed onset muscle soreness (DOMS) phenomenon. The authors describe the main symptoms of DOMS and their relation to different kinds of training strategies, and discuss the most popular muscle pain reduction interventions such as stretching, diet, dietary supplements, nonsteroidal anti-inflammatory drugs (NSAIDs), cryotherapy and cold water immersion, concurrent training, and the repeated bout effect

ANABOLIC-ANDROGENIC STEROIDS SIGNALING

Androgens exert their effects on various parts of the body, including muscles, bones, hair follicles in the skin, liver and kidney, reproductive, hematic, immune and nervous systems. The effects are modulated by specific cellular "steroid-converting" enzymes, located inside target tissues. All the anabolic steroids currently used are derivates of testosterone or changes of its structure. The most important esterified forms of testosterone include the propionate, cipionate, enhantate and undecanoate ones. The mechanism of action of AAS has not been fully elucidated and it is currently subject of many studies. Several mechanism of action have been proposed to identify the path activated by AAS. Some, like oximetholone, does not bind the androgen receptors: it is assumed that these steroids act after a biological transformation into more active compounds. The 5 alpha-reductase, for example, plays a central role in their mechanism of action; on the other hand, aromatase is responsible for the conversion of AAS in female sex hormones such as estradiol and estrone, which bind to the estrogen receptor, forming estrogen-receptor complex. Steroid hormone receptors (SHRs) are members of the superfamily of nuclear and steroid receptors. In particolar, the functions of the androgen receptors (hAR) involving transciption factors are generally regulated by specific steroid ligands, that is androgens and selective androgen receptor modulators (SARMs)

Effects of protein supplementation in fitness world: A 12-week cross-over studio

The aim of this project was to evaluate the effect of isolated protein supplementation in young amateur athletes. Sixteen subjects aged between 20 and 30 were recruited for this study. Before to start sports performance was assessed at T0, in all subjects, using physical performance test and evaluated body composition. Therefore, the subjects were randomly assigned in two groups (group A and B) of 8 subjects each. The group A start to intake 30 g of protein powder diluted in water after each training session (3 times a week) for six weeks (T0) whilst the group B was the placebo. After 6 weeks (T1), the measurement were repeated for all subjects and the group A became placebo and the group B started with the supplementation. At the end of 6 weeks (T2) we carried out all the tests were performed again. Results showed a significant improvement in almost all tests between T0 and T2 within the same group (p < .05), but not significant difference was found between the start and the end of protein’s intake period in both groups. In conclusion, supplementation did not have affect the performance and body composition significantly. Instead, training seems to influence the performance more the supplementation

Physical activity, nutrition and bone health

This review aims to describe the roles that physical activity and nutrition have in bone metabolism and to examine their effects on bone in a situation of altered metabolism as a consequence of inadequate nutrition and/or excessive physical activity. Referring to the recent studies and the main guidelines in the literature on athlete nutrition, the paper also focuses on essential nutrients for bone health during performance. Finally, it discusses the negative effect of some nutrients on bone mineral density

Effects of different circuit training protocols on body mass, fat mass and blood parameters among overweight adults

The benefits of regular exercise are known for a long time, but the mechanisms underlying the exercise mode recommendations for specific chronic cardiovascular diseases remains unclear. The aim of this study was to evaluate and compare the effects of different circuit training protocols in sedentary overweight adults

Dare to jump: The effect of the new high impact activity SuperJump on bone remodeling. A new tool to maintain fitness during COVID-19 home confinement

SuperJump is a high impact activity performed on an elastic trampoline that mixes aerobic and anaerobic exercises already proposed as home-based activity for preventing a sedentary lifestyle. We determined in a randomized controlled trial whether 20 weeks of SuperJump activity would promote bone formation and reduce resorption in eumenorrheic women. Twenty-four women were randomized to a non-exercise group (control group) or an exercise group that performed SuperJump activity three times a week for 20 weeks. Blood samples were collected in both groups at baseline and at the end of the 20 weeks and compared within and between the groups for C-terminal telopeptide (CTX), a marker of bone resorption, osteocalcin, a marker of bone formation, and the markers of bone metabolism parathyroid hormone (PTH), calcitonin, albumin-adjusted calcium (Aa calcium), vitamin D, phosphate and potassium. After 20 weeks of SuperJump activity, levels of CTX were significantly reduced while levels of osteocalcin were increased. PTH, calcium and potassium were involved in the mechanism of action because PTH was reduced while calcium and potassium were increased. Calcitonin, vitamin D and phosphate levels did not change. These data suggest that SuperJump activity is able to reduce bone resorption and improve bone formation by acting on essential regulators of bone metabolism. They also suggest that SuperJump training may be used as a valuable intervention to prevent the occurrence of osteoporosis in aging because it improves bone homeostasis in favor of bone formation and could counteract a sedentary lifestyle, such as during COVID-19 home confinement, which could itself contribute to the variation of bone metabolism. Trial registration: Clinicaltrials.gov NCT04942691 \u2013retrospectively registered